ISB News

Drs. Anthony Fauci, Lee Hood Talk COVID-19, Vaccines, Future of Research, More

ISB’s Dr. Lee Hood presented the PMWC Luminary Award to Dr. Anthony Fauci on Monday, and the two renowned scientists engaged in an interesting hour-long conversation. 

The Luminary Award was presented on behalf of Precision Medicine World Conference on the first day of PMWC COVID, a three-day virtual event. The award recognizes contributions of prominent figures who have accelerated personal medicine to the clinic.

Hood spoke with Fauci, director of the National Institute of Allergy and Infectious Disease, about a number of topics, including the importance of basic research, the extraordinary speed of COVID research, the efficacy of mRNA vaccines on COVID-19 and the technology’s promise for creating effective vaccines for other diseases (including some cancers), lessons learned from the COVID-19 pandemic, and more. 

“We should have a vaccine, as well as universally applicable antivirals, that we could use for the next outbreak,” Fauci said. “I would be really disappointed if when this is over we don’t put together a commission and codify what we need to do as opposed to saying ‘well, we got through that, now let’s worry about the next problem’.”

You can watch the conversation here or by playing the video above.

Recent Articles

  • ISB President Dr. Jim Heath

    ISB Leading NCI Comprehensive Cancer Center to Study Sequential Targeted Inhibitors and Immunotherapies

    The NCI awarded ISB a 5-year, $13 million grant to lead a comprehensive cancer center and study sequential combinations of targeted inhibitors and immunotherapies. The program is designed to determine if the treatments yield greater patient benefit when administered in sequence rather than as monotherapies or as simultaneously administered combinations.

  • 2022 ISB Virtual Microbiome Series

    2022 ISB Virtual Microbiome Series Announced

    Our multi-day microbiome-themed virtual course and symposium is back for the third year! ISB is hosting a two-day course on October 12 & 13, 2022, followed by a symposium on October 14, 2022 on global perspectives in microbiome research. Both events are virtual and free. The intended audience for these events are graduate students, postdocs, principal investigators, industry scientists, educators, clinicians, or any other variety of microbiome-curious people from across the globe.

  • Bugs vs. Drugs: How Our Microbiomes Can Explain Our Response to Statins

    ISB Assistant Professor Dr. Sean Gibbons talked about the science behind statins in our most recent Research Roundtable virtual presentation. His talk was titled “Bugs vs. Drugs: How Our Unique Gut Microbiomes Shape Our Personalized Responses to Statins.”